Oxalic Acid

Oxalic Acid

SCHEMBL7356529

CCCCCCCCCCCCC(C#N)(CCCC(CCc1cccc(OC)c1)N=NC)c1ccccc1.O=C(O)C(=O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EBP Q15125 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PPARG P37231 3/20 0.39
PPARA Q07869 3/20 0.39
EPHX2 P34913 2/20 0.38
CTSL P07711 2/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
STAT3 P40763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL11122865 1.00 EBP (0.44) EBPSIGMAR1KDM4EMEN1KMT2A
Oxalic Acid SCHEMBL11123674 0.97 EBP (0.40) EBPSIGMAR1KDM4EMEN1KMT2A
Oxalic Acid SCHEMBL11117548 0.97 EBP (0.40) EBPSIGMAR1KDM4EMEN1KMT2A
Oxalic Acid SCHEMBL7355984 0.97 EBP (0.40) EBPSIGMAR1KDM4EMEN1KMT2A
Oxalic Acid SCHEMBL7344832 0.97 EBP (0.40) EBPSIGMAR1KDM4EMEN1KMT2A
SCHEMBL11119464 0.97 EBP (0.47) EBPSIGMAR1PPARGPPARAEPHX2
SCHEMBL11119462 0.97 EBP (0.47) EBPSIGMAR1PPARGPPARAEPHX2
Oxalic Acid SCHEMBL11120414 0.95 EBP (0.44) EBPSIGMAR1KDM4EMEN1KMT2A
Oxalic Acid SCHEMBL7348916 0.95 EBP (0.44) EBPSIGMAR1KDM4EMEN1KMT2A
SCHEMBL7349400 0.92 EBP (0.41) EBPSIGMAR1PPARGPPARAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4438131-A CARDIOVASCULAR DISORDERS BASF AKTIENGESELLSCHAFT (DE) 1984-03-20 US disclosed
EP-0064158-A1 Omega-cyano-1, omega-diphenyl azalcane derivatives, their preparation and pharmaceutical preparations containing them BASF Aktiengesellschaft (DE) 1982-11-10 EP disclosed